you are here: HomeNewsIndia

COVID-19 Vaccination in Mumbai: From where to how; all you need to know

Mumbai has received over 1.39 lakh doses of COVID-19 vaccine Covishield, the Brihanmumbai Municipal Corporation (BMC) has said.

January 16, 2021 / 07:45 AM IST
In India, two vaccines have gotten approval for use so far: Covishield and Covaxin.

In India, two vaccines have gotten approval for use so far: Covishield and Covaxin.


India’s financial capital Mumbai, once the country’s coronavirus hotspot, is all set to begin the much-awaited COVID-19 vaccination drive on January 16, alongside the rest of the country.

Prime Minister Narendra Modi will launch India's massive COVID-19 vaccination drive on the day via video conferencing, as doses of vaccines get delivered across the country to all states and Union Territories.

The Drugs Controller General of India (DCGI) had granted emergency use authorisation to two COVID-19 vaccines – Covishield, developed by Oxford University and British-Swedish company AstraZeneca, and manufactured by the Serum Institute of India (SII) and Bharat Biotech's Covaxin.

Also Read: Explained | COVID-19 vaccination drive: How to register, who will get the shots first and other queries answered

In Maharashtra, Chief Minister Uddhav Thackeray will launch the inoculation programme at Jumbo COVID Field Hospital in BKC, Mumbai, at 10 am.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Maharashtra government has so far received 9.83 lakh doses of COVID-19 vaccines. Of these, 9.63 lakh vials are of Covishield vaccine and 20,000 are of indigenously-made Covaxin, according to state Health Minister Rajesh Tope.

Follow our LIVE blog for the latest updates of the novel coronavirus pandemic

Know all about COVID-19 vaccine doses, centres and process of vaccination in Mumbai

Q. How many vials of COVID-19 has been allotted to Mumbai?

The state capital has received over 1.39 lakh doses of Covishield, the Brihanmumbai Municipal Corporation (BMC) said. The civic body said it received 1,39,500 doses of the Covishield vaccine from the SII around 5.30 am on January 13.

The state has also been allotted two thousand doses of Covaxin to the capital city, reported news agency PTI citing Dilip Patil, State Immunization Officer.

So far, 1.3 lakh healthcare workers and around two lakh frontline workers in Mumbai have been reportedly registered for the vaccination through the purpose-built Co-WIN application.

Q. How and where are these vaccines being stored?

The Covishield vaccine doses are being stored at a facility in F-South ward office situated in Parel, said BMC. The civic body has also created a centralised cold storage facility for vaccines in Kanjurmarg.

The centre for Covaxin is Grant Medical College and Sir JJ Group of Hospitals.

Q. At which centres will COVID-19 vaccination be done?

Mumbai will have 72 inoculation centres, said Tope. A minimum of 100 people will be vaccinated against COVID-19 at a single centre, which will have a team of five personnel who will verify the SMS sent to the person to be inoculated, his or her identity and administer the vaccine.

All the necessary arrangement of electricity, Internet and webcasting service has been made at all these centres, the minister has said.

Q. When will the general public receive the vaccine?

It will take six to seven months for the vaccine to become available for those who are not in the high-risk category, said Patil.

Beginning with the healthcare workers, the vaccine will be administered to frontline staff such as police, home guards and others in the second phase.

"Considering the time it would take to administer the vaccine to healthcare workers, frontline staff and people with co-morbid conditions, it would take a minimum of six to seven months for the vaccine to reach the general public," he said.

Q. Who can/cannot take the vaccine?

> The Union Health Ministry has highlighted that under the emergency use authorisation, coronavirus vaccination is indicated only for those who are 18 years and above.

> Interchangeability of COVID-19 vaccines is not permitted. The second dose should also be of the same COVID-19 vaccine which was administered as the first dose. Beneficiaries cannot choose between Covishield and Covaxin vaccines.

Also read | India's COVID-19 vaccine: Who'll get it, when and how - All you need to know

> The health ministry has cautioned against the administration of the vaccine in persons with a history of an anaphylactic or allergic reaction to a previous dose of COVID-19 vaccine, and in those with immediate or delayed onset anaphylaxis or allergic reaction to vaccines or injectable therapies, pharmaceutical products, food items, among others.

> In case of people having active symptoms of SARS-CoV-2 infection, coronavirus infected patients who have been given anti-SARS-CoV-2 monoclonal antibodies or convalescent plasma and acutely unwell and hospitalised patients due to any illness, the COVID-19 vaccination is to be deferred for four to eight weeks after recovery.

> Pregnant and lactating women have not been a part of any COVID-19 vaccine clinical trial so far. Therefore, women who are pregnant or not sure of their pregnancy and lactating women should not receive COVID-19 vaccine at this time, the ministry said.

Q. Do COVID-19 vaccines have any side-affects?

The Union Health Ministry has mentions mild AEFIs (adverse event following immunization) for both the vaccines.

In the case of Covishied, some mild AEFI may occur like injection site tenderness, injection site pain, headache, fatigue, myalgia, malaise, pyrexia, chills and arthralgia and nausea.

Some mild AEFIs in case of Covaxin include injection site pain, headache, fatigue, fever, body ache, abdominal pain, nausea and vomiting, dizziness-giddiness, tremor, sweating, cold, cough and injection site swelling.

Paracetamol may be used to provide symptomatic relief from post-vaccination adverse reactions, the ministry said.

With the addition of 607 fresh cases on January 14, Mumbai's cumulative COVID-19 count has reached 3,01,078, while the death toll has gone up to 11,219, according to the BMC’s data.

(With inputs from PTI)

Follow our full coverage on COVID-19 here.
Somya Lohia
first published: Jan 15, 2021 05:04 pm

stay updated

Get Daily News on your Browser
Sections